| Jan 31,2002 |
Why Is p53 Acetylated? |
|
Recent studies suggest that
acetylation of the p53 tumor suppressor protein is not important
for its DNA binding activity, as was previously thought. We discuss here a number of theories as to how this modification may serve to regulate the protein’s functions.
|
| Jan 30,2002 |
Organogenesis—Heart and Blood Formation from the Zebrafish Point of View |
|
The zebrafish is a
powerful model system that is poised to contribute to our basic understanding of
vertebrate organogenesis. This review develops the theme of modules and illustrates
how zebrafish have been particularly useful for understanding heart and blood
formation.
|
| Jan 29,2002 |
Blocking Caspase-Activated Apoptosis Improves
Contractility in Failing Myocardium |
|
This study investigated the
role of caspase activation in cardiac contractility and sarcomere organization in the development of CHF.
|
| Jan 28,2002 |
Atherosclerosis as an
autoimmune disease:
an update |
|
Here,we summarize
the data on which we have built our immunological hypothesis of
atherogenesis. This concept is based on the observation that almost all
humans have cellular and humoral immune reactions against microbial
heat-shock protein 60 (HSP60).
|
| Jan 27,2002 |
Mucosa-targeted DNA vaccination |
|
Targeting DNA to mucosal sites through a
covalently linked viral adhesin induces
strong mucosal cytotoxic T-cell responses.
Pathways involving two distinct cell types –
dendritic cells and M cells – could mediate
DNA sampling at mucosal surfaces.
|
| Jan 26,2002 |
Part three in the book of genes |
|
Working out the draft sequence of the human genome was a landmark
achievement. But there’s lots more to be done before the finished product is
available. The complete sequence of chromosome 20 sets us on the way.
|
| Jan 25,2002 |
Data, data, everywhere… |
|
To take advantage of this, many branches
of biology may need to be transformed —
moving from bench sciences dominated by
competing research groups into
collaborative enterprises. This would see
entire research communities organized
around databases and associated
computational tools. In such fields, these
online resources could eventually replace
the conventional scientific paper as the
predominant form of communication.
|
| Jan 24,2002 |
The price of tumour suppression? |
|
The p53 protein works to suppress cancer, so one might think that bumping
up the levels of this protein would be a good idea. But this isn’t so — mice
with too much p53 age prematurely.
p53
SIR2
|
| Jan 23,2002 |
Tumor necrosis factor-α converting enzyme |
|
Tumor necrosis factor-α converting enzyme (TACE/ADAM17/CD156q) is a member of the ‘A Disintegrin And
Metalloprotease’, or ADAM, family.
|
| Jan 22,2002 |
Systematic Genetic Analysis
with Ordered Arrays of Yeast
Deletion Mutants |
|
To evaluate function, we developed a method
for systematic construction of double mutants, termed synthetic genetic
array (SGA) analysis, in which a query mutation is crossed to an array of;4700
deletion mutants.
|
| Jan 21,2002 |
Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy |
|
We designed a βA globin gene variant that prevents HbS polymerization
and introduced it into a lentiviral vector we optimized for transfer to
hematopoietic stem cells and gene expression in the adult red blood cell lineage.
|
| Jan 20,2002 |
PPARγ and Atherosclerosis:
Effects on Cell Growth and Movement |
|
TZD activation of PPAR may protect against atherosclerosis both by normalizing proatherogenic metabolic
abnormalities of the insulin resistance/diabetes milieu and through an inhibition of vascular cell growth and movement.
|
| Jan 19,2002 |
Immune Mechanisms in Atherosclerosis |
|
Experimental research has identified several candidate antigens, and there are
encouraging data suggesting that immune modulation as well as immunization can reduce the progression of the disease.
This review provides an overview of our current understanding of the role of immune mechanisms in atherosclerosis.
|
| Jan 18,2002 |
Role of Id Family Proteins in Growth Control |
|
Id proteins (inhibitors of DNA binding/differentiation) are negative regulators of
basic helix-loop-helix (bHLH) type transcription factors, which promote the
differentiation of various cell types.
|
| Jan 17,2002 |
Roads to Polyploidy: The Megakaryocyte Example |
|
Here, we review the mechanisms that lead to this
cell cycle and to polyploidy in megakaryocytes, while also comparing them to
those described for other systems in which high ploidy is achieved.
|
| Jan 16,2002 |
p63 |
|
The p 63 gene, a member
of the p53 gene family, is expressed into at least six protein
isoforms which are divided into two groups, those containing
the transcription activation domain (TA isoforms) and those
that do not (ΔN isoforms).
|
| Jan 15,2002 |
Human Gene Marker/Therapy
Clinical Protocols recommended |
|
The most comprehensive Gene Therapy Protocols,including 472 clinical protocols in America and 38 international ones.
|
| Jan 14,2002 |
Rethinking genetic strategies to study
complex diseases |
|
Understanding the genetic basis of complex diseases is turning out to be
difficult, prompting a widespread (re-)evaluation of the relevant issues.
|
| Jan 13,2002 |
Taking a functional genomics
approach in molecular medicine |
|
The elucidation of genetic components of human diseases at the molecular
level provides crucial information for developing future causal therapeutic
intervention.Here I will discuss the relevance of genome
research for disease gene identification and the future
progress in molecular medicine.
|
| Jan 12,2002 |
Using genetic variation to study
human disease |
|
The study of single nucleotide
polymorphisms (SNPs), the most common type of variant, is likely to
contribute substantially to deciphering genetic determinants of common and
rare diseases.
|
| Jan 11,2002 |
Molecular epidemiology, biomarkers
and cancer prevention |
|
Here we discuss examples of recent susceptibility studies
involving genes, such as those involved in carcinogen metabolism, DNA repair,
cell cycle and immune status, that hold the promise of increasing our
understanding of cancer etiology and possible prevention strategies.
|
| Jan 10,2002 |
Mouse-based phenogenomics for
modelling human disease |
|
Development of
appropriate tools for assessing clinical phenotypes in mice is a crucial
component of these endeavours, as is the establishment of the infrastructure
for archiving and distribution of the growing mutant resource to the
community.
|
| Jan 09,2002 |
Genetics and genomics in infectious
disease susceptibility |
|
Comparative sequence analysis of pathogen strains and functional genomics studies are now underway, hopefully providing new insight into infectious disease susceptibility.
|
| Jan 08,2002 |
Evidence of oxidative damage in
Alzheimer’s disease brain: central role
for amyloid β-peptide |
|
Here,we summarize current research on phospholipid
peroxidation, as well as protein and DNA oxidation, in AD brain, and discuss the
potential role of Aβ in this oxidative stress.
|
| Jan 07,2002 |
DNA fusion vaccines against
B-cell tumors |
|
DNA fusion vaccines containing immuno-enhancing sequences can
augment and direct immune attack on a range of target antigens. Gene-based
fusion vaccines offer ease of manipulation and flexible design to activate
effective attack on cancer.
|
| Jan 06,2002 |
Chromosomal translocations in
sarcomas: prospects for therapy |
|
In the past two decades, cytogenetic and molecular genetic investigations have
revealed that sarcomas are frequently characterized by specific chromosomal
translocations, often involving genes encoding transcription factors.
|
| Jan 05,2002 |
Animal models for respiratory
chain disease |
|
In this review,we present an overview of the field
and discuss in depth a few examples of animal models reproducing pathology
of human disease with primary and secondary respiratory chain involvement.
|
| Jan 04,2002 |
Tumor environment: a potent driving force in
colorectal cancer? |
|
Recent studies
found evidence of dynamic changes in
cellular adhesion and β-catenin localization
occurring during invasion, metastasis and
expansion of well-differentiated colorectal
cancers. It is proposed that such changes
might be driven by the local tumor
environment, which, if validated,would
necessitate a revision of the current linear
tumor progression model.
|
| Jan 03,2002 |
Visualizing the growth of Alzheimer’s Aβamyloid-like fibrils |
|
Seeded growth of Aβ1–40 amyloid-like fibrils
on a mica surface imaged by atomic force
microscopy (AFM).
|
| Jan 02,2002 |
The molecular basis and potential role of survivin in cancer diagnosis
and therapy |
|
Survivin is a recently described molecule that
has been implicated in both the control of cell proliferation and
the regulation of cell lifespan, and is overexpressed in most human
cancers.The exploitation of the survivin signaling pathway might provide
important predictive and prognostic clues in cancer diagnosis, and offer new
therapeutic alternatives for cancer treatment.
|
| Jan 01,2002 |
Vascular Smooth Muscle Growth:Autocrine Growth Mechanisms |
|
|